Get startedLog in
    Picture of Crescita Therapeutics logo

    CTX — Crescita Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    Consumer DefensivesAdventurousMicro CapSuper Stock
    All News

    Brief: Crescita Therapeutics Reports 2018 Third Quarter Results

    Picture of Crescita Therapeutics logoCrescita Therapeutics
    09/11/2018 12:33
    Nov 9 (Reuters) - Crescita Therapeutics Inc  CTX.TO :
    * CRESCITA THERAPEUTICS™ REPORTS 2018 THIRD QUARTER RESULTS
STRONG
ROYALTY REVENUE AND ACHIEVEMENT OF FIRST PLIAGLIS US SALES
MILESTONE POSITIVE ADJUSTED EBITDA OF $0.8M
    * CRESCITA THERAPEUTICS INC - QTRLY TOTAL REVENUE WAS $4.5
MILLION
COMPARED TO $2.7 MILLION IN CORRESPONDING QUARTER OF PRIOR YEAR
    * CRESCITA THERAPEUTICS - TOTAL CASH UTILIZED DURING QUARTER
WAS
$0.9 MILLION, RESULTING IN ENDING CASH & CASH EQUIVALENTS
BALANCE OF $8.2 MILLION AS AT SEPT 30
    * CRESCITA THERAPEUTICS INC - QTRLY NET INCOME FROM
CONTINUING
OPERATIONS PER SHARE $0.02
    * CRESCITA THERAPEUTICS INC - ALL FIGURES IN C$

Source text for Eikon:  ID:nCNW3jw9Pa 
Further company coverage:  CTX.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Crescita Therapeutics

    See all news